How are Non-ST segment elevation myocardial infarction (NSTEMI) and acute coronary syndrome (ACS) patients currently identified? ACS is currently identified through the use of ECGs pre-hospital and ...

Acute coronary syndrome (ACS) in younger patients presents distinctive epidemiological and clinical patterns when compared with older cohorts. Although traditionally viewed as a disease of older ...

INDIANAPOLIS and TOKYO, Aug. 26, 2012 /PRNewswire/ -- Daiichi Sankyo Company, Limited (TSE: 4568) and Eli Lilly and Company (NYSE: LLY) today announced data from the TRILOGY ACS study, a phase III ...

Daiichi Sankyo and Lilly Announce TRILOGY ACS Results Regarding Effient® (Prasugrel) in Acute Coronary Syndrome UA/NSTEMI Patients to be Managed Medically without an Artery-Opening ProcedureStudy did ...

The news reporters obtained a quote from the research from Diagnostica Stago, "To describe the characteristics, frequency of P2Y12-associated complications, adherence and persistence to P2Y12 APT, and ...

PARIS — In patients with suspected acute coronary syndrome (ACS), there was no difference in overall 30-day mortality between a high- and low-usage oxygen protocol in a new study involving the whole ...

Growing evidence suggests that serum cortisol levels are associated with increased cardiovascular mortality in patients with chronic heart failure. Growing evidence suggests that serum cortisol levels ...

Whether the reduced ischemic risk from adding a novel oral anticoagulant (NOAC) to antiplatelets in patients with acute coronary syndromes (ACS) is worth the increased hazard from major bleeding may ...

Infusion of the drug inclacumab at least 1 hour prior to percutaneous coronary intervention (PCI) reduces markers of myocardial damage in patients with non-ST-segment elevation myocardial infarction ...

Human heart attack, computer illustration. The risk for recurrent MACE was high among survivors of a first ever acute coronary syndrome with a substantial number of these being fatal; 34.4% had MACE ...

The number of UA or NSTEMI ACS patients worldwide who are managed without acute coronary interventions, such as PCI, has ranged from 32 percent to almost 60 percent over the last few years. (5,6) In ...